Pre Exposure Prophylaxis News and Research

RSS

HIV diagnosis falls to a record low in NYC, finds report

Reporting of new cases of HIV started in 2001 and since then there has been a steady rise and stability of numbers. In 2018 for the first time in nearly two decades, researchers have reported number of new cases to be below 2,000 over the year. This is a record 67 percent decline in the numbers since 2001, says the report. Further the decline in the numbers has been seen in nearly all age groups between 2017 and 2018.

25 Nov 2019

Penn Nursing receives $100,000 grant for HIV research

Penn Nursing has received a $100,000 grant from the Robert I. Jacobs Fund of the Philadelphia Foundation for HIV research. The grant supports an investigation, "Youth-driven Perspectives in HIV Biomedical Prevention and Cure Research," led by José A. Bauermeister, PhD, MPH, Presidential Professor of Nursing.

20 Nov 2019

New California law may expand use of HIV prevention drugs, with caveats

Kellen Willhite was 24 when he learned he'd been exposed to HIV. What followed was, as he describes it, a second trauma: trying to obtain the drugs that could save him before it was too late.

20 Nov 2019

KHN’s ‘What the Health’: Spending bill slowdown

The fiscal year started a month and a half ago, but Congress has still not agreed on an annual spending bill for the Department of Health and Human Services - or any of the other annual spending bills that fund the government.

14 Nov 2019

New study highlights opportunities to optimize use of PrEP to prevent HIV among sex workers

Preventing HIV in sex workers is a powerful tool in lowering the worldwide burden of the disease, and a new study could help ensure that high-risk women take advantage of medical safeguards.

13 Nov 2019

Study finds fewer new cases of HCV in HIV-negative men who have sex with PrEP-using men

Data from a new study presented this week at The Liver Meeting – held by the American Association for the Study of Liver Diseases – found fewer new cases of hepatitis C infection (commonly called HCV), despite very high rates of other sexually-transmitted infections, in HIV-negative men who have sex with men who take pre-exposure prophylaxis (PrEP) treatments.

10 Nov 2019

Addressing perceived stigma about taking HIV medication can help women at risk

Stigma is an important contributor to the continued HIV epidemic in the United States. While pre-exposure prophylaxis (PrEP) is a medication that can be taken to prevent HIV infection, previous research has shown that a barrier preventing gay, bisexual and other men who have sex with men from using PrEP is fear that partners, family members or community members would believe that those who use PrEP are HIV infected.

4 Nov 2019

Optimal implementation of existing, new interventions essential to end HIV pandemic

Optimal implementation of existing HIV prevention and treatment tools and continued development of new interventions are essential to ending the HIV pandemic, National Institutes of Health experts write in a commentary Clinical Infectious Diseases.

24 Oct 2019

New findings highlight the 'PrEP gap' for men who have sex with men in the EU

This estimate on the "PrEP gap" in Europe was published in a paper in Eurosurveillance today stating that 500 000 men who have sex with men in the European Union currently cannot access HIV pre-exposure prophylaxis (PrEP), despite being very likely to use it.

11 Oct 2019

New $4.5 million federal grant to make more HIV testing available in the Chicago area

More HIV testing will be available in the Chicago area, thanks to a five-year, $4.5 million federal public health grant recently awarded to the University of Chicago Medicine.

3 Oct 2019

New drug delivery system could be a boon for those on a multi-drug regimen

Researchers from the University of North Carolina at Chapel Hill have developed a unique new multi-drug delivery system that could p-rove to be useful for persons who need to take several drugs in a day as part of a regimen.

23 Sep 2019

Drug-sparing HIV regimens have become new standards of care, says GlobalData

Reductions in pill burden and dosing, improvements in safety and tolerability, and increased barriers to resistance have changed HIV management.

17 Sep 2019

HIV diagnoses fall to lowest level since 2000

The number of new HIV diagnoses in the UK has fallen to a record low since 2000, according to a new report by Public Health England.

4 Sep 2019

Vaginal ring used by most women for HIV prevention in open-label study

In an open-label study of women in southern and eastern Africa, a vaginal ring that is inserted once a month and slowly releases an antiviral drug was estimated to reduce the risk of HIV by 39%, according to statistical modeling.

24 Jul 2019

Tailored adherence strategies needed to engage young African women in consistent PrEP use

In a study of open-label Truvada as daily pre-exposure prophylaxis (PrEP) to prevent HIV among 427 young African women and adolescent girls, 95% initiated the HIV prevention strategy, and most used PrEP for the first three months.

24 Jul 2019

Continuation of community-wide HIV testing could lead to reductions in new HIV cases

Continuation of community-wide HIV testing and prompt initiation of treatment as delivered in the HPTN 071 study in South Africa and Zambia could lead to substantial reductions in new HIV cases, be cost-effective, and help to achieve the UNAIDS 2030 targets, according to projections from mathematical modeling and cost-effectiveness analyses presented today at the 10th International AIDS Society Conference on HIV Science in Mexico City.

23 Jul 2019

Even when HIV prevention drug is covered, other costs block treatment

Three years ago, Corey Walsh, who was in a relationship with a man who was HIV-positive, got a prescription for Truvada, a drug approved by the Food and Drug Administration to prevent infection with the virus that causes AIDS.

15 Jul 2019

Europe reports the highest ever levels of syphilis

A new study on syphilis has revealed the horrifying truth that more men than ever are contracting the sexually transmitted infection (STI) syphilis in Europe. The most heavily infected group comprises men having sex with men (MSM). At present, syphilis affects more people than HIV in the European Union.

15 Jul 2019

Scripps CHAVD wins $129 million NIH grant to advance new HIV vaccine approach

The Scripps Consortium for HIV/AIDS Vaccine Development, an international collaboration led by Scripps Research, has received a $129 million grant from the National Institutes of Health to advance next-generation vaccines designed to coax the immune system into producing antibodies capable of disarming numerous strains of HIV.

11 Jul 2019

Long-acting contraceptives do not increase risk of HIV, concludes new study

One of the largest and most robust studies on HIV infection rates has concluded that long-acting contraceptives do not increase the risk of contracting HIV.

14 Jun 2019